Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center

NCT05095948 | Not Yet Recruiting

• 2 other identifiers: 2020-0246NCI-2021-10266
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

This study examines how cancer care is delivered in oncology and supportive care clinics. Collecting patient feedback may help doctors better understand the processes of cancer care in oncology and supportive care clinics.

Conditions

Metastatic Malignant Solid Neoplasm

Outcome Measures

Primary Outcomes (1)

• Minutes spent in discussion

  Will be examined using linear mixed models (LMMs) with physician as the unit of analysis.

  through study completion, an average of 1 year

Study Arms (1)

Supportive Care (questionnaire, clinic conversation)

Patients complete questionnaires over 15-20 minutes and undergo audio recording of clinic conversations between the oncology team or the specialist palliative care team. Patients' medical records are also reviewed.

Procedure: Discussion; Other: Electronic Health Record Review; Other: Questionnaire Administration

Interventions

Discussion PROCEDURE

Undergo audio recording of clinic conversations

Also known as: Discuss

Supportive Care (questionnaire, clinic conversation)

Electronic Health Record Review OTHER

Review of medical records

Supportive Care (questionnaire, clinic conversation)

Questionnaire Administration OTHER

Complete questionnaires

Supportive Care (questionnaire, clinic conversation)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients within 6 months of diagnosis of metastatic (or stage IV) solid malignancies

You may qualify if:

• Within 6 months of diagnosis of metastatic (or stage IV) solid malignancies
• Age 18 or greater
• English speaking
• Follow-up clinic visit (Supportive Care and Medical Oncology Outpatient Clinics at MD Anderson Cancer Center)
• Medical oncologist listed as the attending physician
• COHORT A (Oncology team only cohort): Patients should not have been referred to palliative care services at MD Anderson Cancer Center
• COHORT B (Oncology team and specialist palliative care cohort): Patients should have an upcoming specialist palliative care follow-up visit within 1 week of a medical oncology visit

You may not qualify if:

• Delirium (Memorial Delirium Assessment Scale \[MDAS\] \>= 13/30)
• Significant hearing impairment requiring multiple repetitions during the screening process (that may prolong clinic time)

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• MD Anderson Cancer Center

MeSH Terms

Conditions

Neoplasm Metastasis

Condition Hierarchy (Ancestors)

Neoplastic Processes; Neoplasms; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• David Hui

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Central Study Contacts

David Hui, MD

CONTACT

(713) 792-6258; dhui@mdanderson.org

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 12, 2021
• First Posted: October 27, 2021
• Study Start (Estimated): August 30, 2026
• Primary Completion (Estimated): September 30, 2026
• Study Completion (Estimated): September 30, 2026
• Last Updated: March 9, 2026

Record last verified: 2026-03

Locations

US (1)